HR 1406 · in committee · significant
Lung Cancer Screening and Prevention Act of 2025
- healthcare
What this bill does
- Medicare will cover additional FDA-approved lung cancer screening tests beyond those recommended by the Preventive Services Task Force.
- Medicare beneficiaries seeking lung cancer screening will have access to a broader range of approved tests.
- CMS will establish coverage limits and payment rates for the newly covered screening tests.
Generated by claude-haiku-4-5
Community Threads
Started by Cosponsor
- 01
How would expanding Medicare lung cancer screening beyond current task force recommendations affect total program costs and beneficiary access?
- 02
Which populations would benefit most from coverage of additional FDA-approved screening tests, and are there equity considerations in implementation?
- 03
What evidence supports covering screening tests beyond task force recommendations, and how would CMS determine appropriate payment rates?
Cosponsor writes these to seed civic discussion — they aren't user posts. Sign in to reply.
Sponsor · R-FL-16
Vern Buchanan
Citizen cosponsors
0
In Congress
8/ 435
House Reps cosponsoring
Introduced 2025-02-18
Joining the bill
Legislative timeline
2025-02-18 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-02-18 · house · IntroReferral
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-02-18 · IntroReferral
Introduced in House
2025-02-18 · IntroReferral
Introduced in House
Citizen comments
Sign in to comment on this bill.
No comments yet — be the first.